How does the bio 3D printing up-and-coming profile challenge the giant Organovo?
Recently, in the field of bio 3D printing, the name Aspect Biosystems has frequently appeared in people's field of vision. The 3D human tissue printing technology developed by the company has won many international awards, successfully transforming the concept of organ 3D printing into reality, and has been consistently praise. What kind of team and achievements have made this company an award-winning company in just three years and has become the leader in many 3D printing companies. Company business card Company Name: Aspect Biosystems Company Ownership: Vancouver, Canada Industry: Biotechnology, 3D printing Company President: Tamer Mohamed Founding team: President and CEO Tamer Mohamed, Chief Technology Officer Dr. Konrad Walus, Chief Scientific Officer Dr. Sam Wadsworth, Chief Operating Officer Simon Beyer Core technology: lab-on-a-printer technology 3D printing organization product: 3DAirwayALITM 3DBioRingTM Airway Financing situation: Successful completion of seed round financing from local angel investors in Vancouver in 2015 and oversubscription Awards: 1 2015.10.2 Canadian Regional Entrepreneurship Association Award 2 2016.7.7 Science and Technology Award Aspect Biosystem is a biotechnology start-up company based in Vancouver, Canada, established in November 2013. As a derivative company of UBC University, it is committed to the development of a bio 3D printing technology platform, focusing on human tissue functions and developing bio 3D printing technology. The bio 3D printer developed by it can print human tissues with comprehensive biological functions using different cells, biological materials and growth factors, and can be used for testing dangerous or experimental drugs, or for manufacturing portable biological organs. This 3D technology will make a breakthrough contribution to the future of medical and drug research and development. Core research team Aspect Biosystems' 3D technology research team, created by Dr. Walus of Columbia University in Canada and other world-class biologists and engineers, has successfully turned the concept of bio 3D printing technology into a commercial product. By using its unique bio-printing technology, the living cell material is fused with a liquefied hydrogel, injected into a 3D printer and extruded into a specific shape, and then the production results are hatched and cultured, and a biologically active living tissue is created. 3D Technology Research Team The successful development of this technology not only reduces the cost of drug development, but also eliminates the inherent unreliability of animal Drug Testing. Various studies have shown that this bio-3D printing technology can more realistically simulate the internal conditions of the human body, thus helping doctors and researchers to find the best and least harmful drugs and treatments for patients. CEO Tamer Mohamed Molecular Biolab Equipment,Seqstudio Genetic Analyzer,Gene Sequencer Forensic Testing Equipment,Lab Clinical Instrument Nanjing Superyears Gene Technology Co., Ltd. , https://www.superyearsglobal.com.jpg)
.jpg)
.jpg)